Biocanto Pharma sp. z o.o.

Manufacture of basic pharmaceutical products

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2017-05-30
Share capital
720,000.00 PLN
Activity description

Biocanto Pharma operates in the pharmaceutical sector and is part of the Investcare Pharmaceutical Group. For nearly three decades, it has supplied pharmacies with medicines, medical devices and dietary supplements, following storage standards for these products.

Registered address
Białobrzeska 45, 41-409 Mysłowice, Poland
Email
Phone
Social media

Financials

Revenue history (in k)

From the notes

Profit allocationNo decision

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 27 days late).

  • 202519/06/2026
  • 202401/07/2025
  • 202325/06/2024
  • 202213/06/2023
  • 202111/08/2022
  • 202001/10/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Sector · Manufacturing22,872 / 33,831
Top 68%
Voivodeship · Śląskie25,794 / 51,392
Top 50%
Country · Poland244,278 / 496,512
Top 49%

Results vs industry

Revenue
This companyUSD 186.10kMedianUSD 165.97kAverageUSD 2.30m
Net profit
This companyUSD -63.16kMedianUSD 1.32kAverageUSD 109.80k
Operating costs
This companyUSD 249.26kMedianUSD 201.81kAverageUSD 2.10m
Assets
This companyUSD 130.48kMedianUSD 118.27kAverageUSD 1.54m

Offer

Websites

  • biocanto.plBiocanto
    WordPress 7.1ElementorGoogle AnalyticsGoogle Tag ManagerMeta PixelYoast SEOLiteSpeed

Authorized Representatives

Agata Stanisława Empfinger age 49 – Attorney-in-fact (joint)
Ewelina Górska age 51 – Attorney-in-fact (joint)
Grzegorz Piechota age 50 – President of the Management Board
Kamil Okólski age 32 – Vice President of the Management Board

Manner of representation

In the case of a one-person management board, declarations of will on behalf of the company are made by the member of the management board. In the case of a management board consisting of two or more persons, the joint action of two members of the management board or of one member of the management board jointly with a commercial proxy is required to make declarations of will on behalf of the company.

Supervisory board

Adam Marcin Pecyna age 50 – Supervisory Board Member
Artur Zarzecki age 31 – Supervisory Board Member
Małgorzata Beata Bieńkowska age 63 – Supervisory Board Member
Ewa Nowosielska age 53 – Supervisory Board Member
Łukasz Stanisław Nowak age 47 – Supervisory Board Member

Ownership

OwnerSharesShare valueStake
2,400$32,414.9116.6667%
2,400$32,414.9116.6667%
2,400$32,414.9116.6667%
2,400$32,414.9116.6667%
2,400$32,414.9116.6667%
2,400$32,414.9116.6667%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2025-01-01.

  • mBank
    85 1140 1049 0000 7461 9300 1002
  • mBank
    15 1140 1049 0000 7461 9300 1001
  • mBank
    31 1140 1049 0000 7461 9300 1004

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name
Investcare S.A.
Kleemed Pharmaceuticals Poland sp. z o.o.
Pharmnew sp. z o.o.
Sincofarm sp. z o.o.
Bonopharm sp. z o.o.
Ananta Medicare Poland sp. z o.o.
Kolpharma sp. z o.o.
Pharmatonica sp. z o.o.
Toto Pharma Poland sp. z o.o.
MB Pharma sp. z o.o. + limited partnership

Change history

DateEvent
2025-04-04Share capital increase
2025-04-04Name change
2025-04-04Switch to PKD 2025
2024-12-16Address change
2023-09-28Share capital increase

FAQ

Last updated: 2026-06-19